Craig Venter tells Industrial Biotechnology that his and his colleagues' development of a synthetic genome showed that DNA is somewhat like a software system that can be programmed, and that proof-of-principle study can to applied broadly to a number of societal challenges.

For instance, Venter notes that his company Synthetic Genomics is focused on developing cells as a source of food, vaccines, antimicrobials, and, in the longer run, fuel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.